These are the targeted clinical approaches used to modulate the concentration of Sex Hormone-Binding Globulin (SHBG), a glycoprotein that binds circulating testosterone and estradiol, thereby controlling the fraction of biologically active (free) hormone. Effective management aims to shift SHBG levels to optimize the free hormone index, which is the true indicator of tissue exposure. Strategies address underlying drivers like liver function or insulin resistance.
Origin
The term is specific to endocrinology, referencing SHBG, the protein synthesized predominantly by the liver, and “management strategies,” the interventions employed to influence its concentration. Its importance stems from the fact that total hormone assays are often misleading without considering SHBG as the primary regulator of hormone transport and bioavailability.
Mechanism
Strategies function by targeting the factors that govern hepatic SHBG synthesis. For instance, improving insulin sensitivity or reducing hyperinsulinemia often leads to a decrease in SHBG, thus increasing free testosterone availability. Conversely, certain conditions or substances can increase SHBG, necessitating intervention to prevent symptomatic androgen or estrogen deficiency despite normal total hormone levels. The mechanism is primarily metabolic regulation impacting hepatic transcription.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.